“…According to their data, the time for the most change in size was between 5 and 10 years. [1] Conclusion:-Our meta-analysis supported that factors significantly favor tumor growth are younger patients age, larger initial tumor size, T2 hyper intensity, peri-tumoral edema. While only intra-tumoral calcification significantly favor slow or even no tumor grows.…”
Section: Growth Rates:-mentioning
confidence: 58%
“…Twelve studies reported patients that ultimately underwent surgery [1,4,5,6,7,8,13,14,16,17,21,23]. Among patients with growing tumors, 27.8% underwent surgery, either open, radiosurgery, or both.…”
Section: Growth Rates:-mentioning
confidence: 99%
“…Published reports are often limited by a retrospective study design, small sample size, and short follow-up period. [1][2][3][4][5][6][7][8][9][10][11][12][13][14]16,17,19,[21][22][23] A systematic review and meta-analysis of the studies currently available allows for a better understanding of the natural course of asymptomatic meningiomas, a platform for more research, and a foundation on which a standardized guideline for following these tumors may be built.…”
“…According to their data, the time for the most change in size was between 5 and 10 years. [1] Conclusion:-Our meta-analysis supported that factors significantly favor tumor growth are younger patients age, larger initial tumor size, T2 hyper intensity, peri-tumoral edema. While only intra-tumoral calcification significantly favor slow or even no tumor grows.…”
Section: Growth Rates:-mentioning
confidence: 58%
“…Twelve studies reported patients that ultimately underwent surgery [1,4,5,6,7,8,13,14,16,17,21,23]. Among patients with growing tumors, 27.8% underwent surgery, either open, radiosurgery, or both.…”
Section: Growth Rates:-mentioning
confidence: 99%
“…Published reports are often limited by a retrospective study design, small sample size, and short follow-up period. [1][2][3][4][5][6][7][8][9][10][11][12][13][14]16,17,19,[21][22][23] A systematic review and meta-analysis of the studies currently available allows for a better understanding of the natural course of asymptomatic meningiomas, a platform for more research, and a foundation on which a standardized guideline for following these tumors may be built.…”
“…Meningiomas represent 13-26% of all intracranial masses with a female to male ratio of 2:1 and most often occur beyond the 5th decade. [11][12][13][14] On CT, meningiomas may show associated hyperostosis as a supportive finding and approximately 75% appear hyperattenuating to brain. Classic MRI appearances are those of a T1 and T2 isointense lesion with avid contrast enhancement and an enhancing dural "tail", but this is not a necessary or pathognomonic feature ( Fig.…”
Section: Meningiomamentioning
confidence: 99%
“…Depending on their size and location, these lesions may be surprisingly indolent, but certain features such as progressive optic nerve compromise can require emergency intervention. 14 …”
Skull base imagingHead and neck
Skull base tumours
Oncology a b s t r a c tThe skull base is a highly complex and difficult to access anatomical region, which constitutes a relatively common site for neoplasms. Imaging plays a central role in establishing the differential diagnosis, to determine the anatomic tumour spread and for operative planning. All skull base imaging should be performed using thin-section multiplanar imaging, whereby CT and MRI can be considered complimentary. An interdisciplinary team approach is central to improve the outcome of these challenging tumours.
Background
Grade II and III meningiomas have higher rates of tumor recurrence than grade I meningiomas after surgery and/or external irradiation. As the utility of non-invasive treatments for brain tumors increases, it is becoming increasingly important to assess the likelihood that a tumor is not benign before treatment initiation. Hence, we have reviewed a large-series of our patients to determine risk-factors for higher-grade pathology with particular interest paid towards tumor location.
Methods
We reviewed 378 patients presenting to our institution from 2000 to 2007 with: histologically confirmed meningioma, central pathology grading according to the WHO 2000 guidelines, and tumor location confirmed with preoperative imaging. We performed univariate and multivariate logistic regression on potential risk-factors for high-grade pathology.
Results
Risk-factors for grade II/III pathology included non-skull base location (twofold) and male gender (two-fold). Patients with prior surgery had a three-fold increased incidence of higher-grade meningiomas at presentation to our center. We controlled for this referral bias by performing a multivariate regression, and analysis without patients receiving prior treatment. 97% of operations were performed for tumor size and clinical symptoms, while less than 3% for interval growth or features concerning of higher-grade pathology.
Conclusion
Non-skull-base meningiomas, male gender, and prior surgery impart increased risk for grade II or III pathology. This increased risk translates to probable poorer prognosis and increased likelihood of recurrence after treatment. Thus, it is prudent to take these specific variables into consideration in conjunction with the complete clinical presentation when advising patients regarding their prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.